Sabirnetug clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2021
How each study uses sabirnetug is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2024 (2)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Acumen Pharmaceuticals (3)
Studies
Open first, then newest update. How each study uses sabirnetug is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)Active, not recruitingPhase 2Acumen PharmaceuticalsNCT06335173Written as sabirnetugHow we know
- A Study Comparing the Safety, Tolerability, and Pharmacokinetics of Sabirnetug IV and Sabirnetug + rHuPH20 SC in Healthy ParticipantsCompletedPhase 1Acumen PharmaceuticalsNCT06511570Written as sabirnetug (ACU193)How we know
- A Study to Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild ADCompletedPhase 1Acumen PharmaceuticalsNCT04931459Written as ACU193How we know
Codes
What other systems call sabirnetug · ClinicalTrials.gg INT014531
- UNII (FDA) 2U1A25MKP9SABIRNETUGOne source FDA
- NCI Thesaurus C199109SabirnetugOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 2U1A25MKP9 | SABIRNETUG | One source FDA |
| NCI Thesaurus | C199109 | Sabirnetug | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.